NovoCure Ltd — Director's Dealing 2019

Jun 12, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2019-06-10

Reporting Person: Shah Pritesh (Chief Commercial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-06-10	Ordinary Shares	S	1070	$55.024	Disposed	76272	Direct
2019-06-10	Ordinary Shares	S	60	$55.60	Disposed	76212	Direct

Footnotes

F1: On June 10, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Shah, Mr. Shah sold 1,070 shares in multiple trades at prices ranging from $54.60 to $55.50. The price reported above reflects the weighted average sale price. Mr. Shah hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

F2: Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Shah.